Skip Navigation
medication-assisted treatment for substance use disorders

Clinical Challenges in Opioid Prescribing: Balancing Safety and Efficacy

Purpose of the Courses

Each year, millions of patients are treated with prescription opioid drugs for a variety of serious medical conditions. This free SAMHSA-sponsored course will help medical professionals address the balance between providing optimal pain relief and preventing inappropriate use of opioid analgesics, including avoiding adverse outcomes for their patients, for the community, and for themselves. Primary care physicians constitute the principal audience for the course, although physician extenders such as independent nurse practitioners and physician assistants are also welcome.

This activity has been approved for AMA PRA Category 1 Credit(s)TM.

Educational Objectives

On completing this course, participants will be able to:

  • Describe the nature of chronic pain and options for its treatment.
  • Select patients who are appropriate candidates for opioid management of chronic pain.
  • Define risk factors for potential misuse, abuse, and diversion of prescribed opioid medications.
  • Recognize the importance of consistent screening for risk prior to prescribing.
  • Outline a time-efficient method of conducting risk screening.
  • Follow an evidence-based protocol for starting patients on opioid analgesic therapy, including safely initiating and titrating opioids.
  • Monitor patients’ response to opioids and address problems such as inadequate response to treatment.
  • Recognize problematic or aberrant drug-taking behaviors and be able to distinguish unintentional misuse, pseudoaddiction, or chemical coping from deliberate misuse, abuse, and diversion.
  • Outline a time-efficient approach to dealing appropriately with aberrant drug-taking behaviors, including referral to specialized addiction treatment programs when indicated.

Continuing Medical Education Credits

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Postgraduate Institute for Medicine and SAMHSA. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education (CME) for physicians.

PIM logo
The Postgraduate Institute for Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Typical Program

The course lasts 6–8 hours. However, the length of the course is customized to the needs of the target audience.

2015 CME Course – Clinical Challenges in Opioid Prescribing: Balancing Safety and Efficacy on PRESCRIBING OPIOIDS FOR CHRONIC PAIN*

Date and Time:June 17, 6 pm–8 pm to June 18, 8:30 am–2:30 pm
Site: Menomonie, Wisconsin
Cosponsor: Held in conjunction with the National Rural Institute on Alcohol and Drug Abuse Conference
Faculty: Theodore Parran, Jr., MD, FACP; Anton C. Bizzell, MD
CME Credits: The Postgraduate Institute for Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™.
Registration: www.uwstout.edu/profed/nri/reg.cfm (Postconference Attendee-Only Registration)
   
Date and Time: July 29, 8 am–5 pm
Site: Tulalip, Washington
Cosponsor: Held in conjunction with the Association of American Indian Physicians (AAIP) 44th Annual Meeting & National Health Conference
Faculty: Theodore Parran, Jr., MD, FACP; John Hopper, MD, FAAP, FACP, FASAM
CME Credits: To be announced
Registration: www.regonline.com/opioidcme2015-washington
   
Date and Time: July 31, time to be announced
Site: St. Louis, Missouri
Cosponsor: Held in conjunction with the National Conference on Addiction Disorders
Faculty: Theodore Parran, Jr., MD, FACP; to be announced
CME Credits: To be announced
Registration: To be announced
   
Date and Time: To be announced
Site: Phoenix, Arizona
Cosponsor: University of Arizona College of Medicine
Faculty: To be announced
CME Credits: To be announced
Registration: To be announced
   
Date and Time: To be announced
Site: Tucson, Arizona
Cosponsor: University of Arizona College of Medicine
Faculty: To be announced
CME Credits: To be announced
Registration: To be announced>
   
Date and Time: To be announced
Site: Indiana
Cosponsor: State Opioid Treatment Authorities
Faculty: To be announced
CME Credits: To be announced
Registration: To be announced
   
Date and Time: To be announced
Site: Kentucky
Cosponsor: University of Kentucky College of Medicine, Lexington
Faculty: To be announced
CME Credits: To be announced
Registration: To be announced
   
Date and Time: Available 24/7; no fee
Site: Accessible from anywhere in the United States via the Web
Cosponsor: Boston University School of Medicine (S); Massachusetts Board of Medical Licensure (CS) www.opioidprescribing.com
Faculty: Dan Alford, MD, John Renner, MD
CME Credits: 4 modules; 1 credit per module
   

_______________________________________________________________________________________________ * as of May 1, 2015

For more information about these courses, contact:

  • Melinda Campopiano von Klimo, MD
    Medical Officer, Center for Substance Abuse Treatment
    Substance Abuse and Mental Health Services Administration
    1 Choke Cherry Rd., Room 7-1017
    Rockville, MD 20857
    Melinda.Campopiano@samhsa.hhs.gov
    Phone: 240-276-2701
    Fax: 240-238-2894

Acknowledgements

Technical and financial support for the course is granted JBS International, Inc., under contract HHSS28320070003I/HHSS28342007T with the Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services. LCDR Brandon Johnson, MBA, and LCDR Sidney Hairston, both of the Division of Pharmacologic Therapies of the Center for Substance Abuse Treatment, serve as Government Project Officers. Robert Lubran, MS, MPA, the director of the Division of Pharmacologic Therapies, and Melinda Campopiano, MD, medical officer for the Center for Substance Abuse Treatment, provided valuable guidance, as did other experts within government agencies and private-sector organizations. Jane Maxwell, PhD, research professor at the Addiction Research Institute at the School of Social Work, University of Texas at Austin, has updated the data for the curriculum.

Faculty for this year’s live course include:

Louis Baxter, Sr., MD, FASAM
Executive Medical Director, Professional Assistance Program of New Jersey, and Director, American Board of Addiction Medicine, and Immediate Past President, American Society of Addiction Medicine, Chevy Chase, Maryland
Anton C. Bizzell, MD
President and CEO, The Bizzell Group, LLC
James W. Finch, MD
Medical Director, Changes by Choice, Durham, North Carolina, and Director of Physician Education, North Carolina Governor’s Institute on Alcohol and Drug Abuse
John Hopper, MD, FAAP, FACP, FASAM
Residency Program Director and Vice Chair for Education, Department of Internal Medicine, St. Joseph Mercy Hospital, and Clinical Associate Professor of Internal Medicine, Pediatrics, Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan
Theodore V. (Ted) Parran, Jr., MD, FACP
Carter and Isabel Wang Professor of Medical Education, and Chair, Medical Education, and Addiction Medicine Fellowship Co-Director, Case Western Reserve University School of Medicine, Cleveland, Ohio
Stephen Wyatt, DO
Director, Dual Diagnosis Program, Middlesex Hospital, Middletown, Connecticut

Disclaimer

The views expressed in this course and related materials do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
Note to users of screen readers and other assistive technologies: Please report your problems
to us at otp-extranet@opioid.samhsa.gov.
link to the Substance Abuse & Mental Health Services Administration division of pharmacologic therapies logo